Moneycontrol PRO
Loans
Loans
HomeNewsTrendsHealth‘COVID-19 isn’t over’: PM Modi chairs high-level review meet

‘COVID-19 isn’t over’: PM Modi chairs high-level review meet

Reiterating that COVID-19 isn’t over, PM Modi cautioned against complacency and advised strict vigil. He also directed government officials to strengthen the ongoing surveillance measures, especially at international airports.

December 22, 2022 / 20:35 IST
PM Modi (Image: Twitter/@narendramodi)

Prime Minister Narendra Modi on December 22 chaired a high-level meeting to assess the COVID-19 situation in the country, the preparedness of health infrastructure and logistics, the status of the vaccination campaign, and the emergence of new SARS-CoV-2 variants and their public health implications for the country.

This high-level review meeting comes against the backdrop of a spike in COVID-19 cases in some countries, including China.

The meeting was attended by Union Minister Amit Shah, Union Health Minister Dr Mansukh Mandaviya, Minister of Civil Aviation Jyotiraditya Scindia, and MEA Dr S Jaishankar among others. NITI Aayog CEO Parameswaran Iyer, NITI Aayog Member (Health) Dr V K Paul, and Home Secretary AK Bhalla, were among senior government officials who were present at the meeting.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

At the COVID-19 review meet, a comprehensive presentation was made regarding the global coronavirus situation including the rising cases in countries by Secretary, Health and Member, NITI Aayog.

The Prime Minister was briefed that India has been witnessing a steady decline in cases with average daily cases falling to 153 and weekly positivity down to 0.14 percent in the week ending December 22, 2022. However, 5.9 lakh daily average cases have been reported globally in the past six weeks.

Reiterating that COVID-19 isn’t over, PM Modi cautioned against complacency and advised strict vigil. He also directed government officials to strengthen the ongoing surveillance measures, especially at international airports.

The Prime Minister then went on to stress the need to ensure that the entire COVID-19 infrastructure at all levels is maintained at a high level of preparedness in terms of equipment, processes and human resources. He advised states to audit COVID-19-specific facilities to ensure the operational readiness of hospital Infrastructure, including oxygen cylinders, PSA plants, ventilators and human resources.

Meanwhile, officials have been directed to ramp up testing and genomic sequencing efforts and states have been asked to share a larger number of samples with the designated INSACOG Genome Sequencing Laboratories (lGSLs) for genome sequencing on a daily basis. This would support the timely detection of newer variants, if any, circulating in the country and facilitate undertaking requisite public health measures.

PM Modi has asked everyone to follow coronavirus-appropriate behaviour at all times, especially in view of the upcoming festive season, including wearing masks in crowded public places. He also urged encouragement to take precautionary doses, especially for vulnerable and elderly persons.

At the meeting, the PM was informed that there is adequate availability of medicines, vaccines and hospital beds; he advised to regularly monitor the availability and prices of essential medicines.

Moneycontrol News
first published: Dec 22, 2022 08:09 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347